Susan Grandy

3.0k total citations
73 papers, 2.4k citations indexed

About

Susan Grandy is a scholar working on Endocrinology, Diabetes and Metabolism, Public Health, Environmental and Occupational Health and Surgery. According to data from OpenAlex, Susan Grandy has authored 73 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Public Health, Environmental and Occupational Health and 12 papers in Surgery. Recurrent topics in Susan Grandy's work include Diabetes Treatment and Management (22 papers), Diabetes Management and Research (20 papers) and Diabetes Management and Education (12 papers). Susan Grandy is often cited by papers focused on Diabetes Treatment and Management (22 papers), Diabetes Management and Research (20 papers) and Diabetes Management and Education (12 papers). Susan Grandy collaborates with scholars based in United States, United Kingdom and Sweden. Susan Grandy's co-authors include Kathleen M. Fox, Richard H. Chapman, Harold Bays, Karin S. Coyne, Andrew Green, Peter Zimetbaum, Matthew W. Reynolds, Marco Mercader, Clark Paramore and Helena W. Rodbard and has published in prestigious journals such as PLoS ONE, Diabetes Care and Anesthesiology.

In The Last Decade

Susan Grandy

72 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Susan Grandy United States	28	996	610	357	346	265	73	2.4k
Gerardo Heiss United States	17	727 0.7×	926 1.5×	586 1.6×	396 1.1×	228 0.9×	18	2.6k
Chris Isles United Kingdom	20	1.2k 1.2×	924 1.5×	878 2.5×	556 1.6×	249 0.9×	73	3.2k
Christopher Ll. Morgan United Kingdom	32	1.4k 1.4×	346 0.6×	435 1.2×	398 1.2×	394 1.5×	80	3.4k
Carl Johan Östgren Sweden	32	963 1.0×	881 1.4×	400 1.1×	386 1.1×	707 2.7×	145	2.9k
Josep Franch‐Nadal Spain	30	1.9k 1.9×	582 1.0×	338 0.9×	660 1.9×	301 1.1×	228	3.3k
Carla Yunis United States	27	524 0.5×	607 1.0×	448 1.3×	140 0.4×	539 2.0×	47	2.6k
Eleni Rapsomaniki United Kingdom	16	762 0.8×	1.6k 2.6×	400 1.1×	418 1.2×	312 1.2×	38	3.1k
Imad M. El‐Kebbi United States	26	2.1k 2.2×	456 0.7×	301 0.8×	569 1.6×	430 1.6×	38	3.4k
Mogens Lytken Larsen Denmark	23	530 0.5×	750 1.2×	270 0.8×	199 0.6×	189 0.7×	86	2.0k
David C. Ziemer United States	27	2.3k 2.3×	523 0.9×	298 0.8×	676 2.0×	196 0.7×	57	3.6k

Countries citing papers authored by Susan Grandy

Since Specialization

Citations

This map shows the geographic impact of Susan Grandy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Grandy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Grandy more than expected).

Fields of papers citing papers by Susan Grandy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Grandy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Grandy. The network helps show where Susan Grandy may publish in the future.

Co-authorship network of co-authors of Susan Grandy

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Grandy. A scholar is included among the top collaborators of Susan Grandy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Grandy. Susan Grandy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morgan, Christopher Ll., Qing Qiao, Susan Grandy, et al.. (2018). Glucose Control and Weight Change Associated with Treatment with Exenatide Compared with Basal Insulin: A Retrospective Study. Diabetes Therapy. 9(1). 269–283. 5 indexed citations

Chen, Stephanie, et al.. (2017). Glucagon-like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Naïve Patients with Type 2 Diabetes Mellitus: A Multinational Preference Study. Diabetes Therapy. 8(2). 321–334. 30 indexed citations

Rohwedder, Katja, et al.. (2014). Change in quality of life (EQ-5D) among type 2 diabetes mellitus patients inadequately controlled with metformin plus sulfonylurea and treated with dapagliflozin as triple therapy regimen for 24 weeks. Value in Health. 17(3). A257–A257. 1 indexed citations

Bays, Harold, Kathleen M. Fox, & Susan Grandy. (2014). Validated functional scales among adults with and without type 2 diabetes mellitus: study to help improve early evaluation and management of risk factors leading to diabetes (SHIELD). 3(1). 1–1. 2 indexed citations

Trautmann, Matthias, Javier Sabater, James W. Shaw, et al.. (2014). Relevance of clinical trials to inform HTA: Disparity between hta evidence requirements and published rcts in type 2 diabtetes mellitus. Value in Health. 17(3). A263–A263. 1 indexed citations

Bujac, Sarah R., Angelo Del Parigi, Jennifer Sugg, et al.. (2014). Patient Characteristics are not Associated with Clinically Important Differential Response to Dapagliflozin: a Staged Analysis of Phase 3 Data. Diabetes Therapy. 5(2). 471–482. 10 indexed citations

Grandy, Susan, Kathleen M. Fox, & Elise Hardy. (2013). Association of Weight Loss and Medication Adherence Among Adults With Type 2 Diabetes Mellitus: SHIELD (Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes). Current Therapeutic Research. 75. 77–82. 43 indexed citations

Bergenheim, Klas, Susan Grandy, & Gail Wygant. (2013). Cost of Achieving Relevant Composite Endpoint of HbA1c<7%, No Hypoglycaemia and Weight Loss of ≥3% in a 52 Week Post-Hoc Analysis of Dapagliflozin Versus Glipizide. Value in Health. 16(7). A439–A439. 1 indexed citations

Grandy, Susan, et al.. (2012). Change in health status (EQ-5D) over 5 years among individuals with and without type 2 diabetes mellitus in the SHIELD longitudinal study. Health and Quality of Life Outcomes. 10(1). 99–99. 66 indexed citations

10.

Green, Andrew, Kathleen M. Fox, & Susan Grandy. (2012). Self-reported hypoglycemia and impact on quality of life and depression among adults with type 2 diabetes mellitus. Diabetes Research and Clinical Practice. 96(3). 313–318. 89 indexed citations

11.

Heintjes, Edith M., Fernie J. A. Penning‐van Beest, Shreekant Parasuraman, et al.. (2011). PCV32 Population Attributable Risk (PAR) of Macrovascular Events Associated with HbA1C, Blood Pressure or Weight in Patients with Type 2 Diabetes Mellitus: Evidence from a Dutch Cohort. Value in Health. 14(7). A370–A370. 4 indexed citations

12.

Gavin, James R., Kathleen M. Fox, & Susan Grandy. (2011). Race/Ethnicity and gender differences in health intentions and behaviors regarding exercise and diet for adults with type 2 diabetes: A cross-sectional analysis. BMC Public Health. 11(1). 533–533. 33 indexed citations

13.

Lewis, Sandra, et al.. (2009). Underutilisation of cardiovascular medications among at-risk individuals. International Journal of Clinical Practice. 64(5). 604–610. 7 indexed citations

14.

Lewis, Sandra J., et al.. (2009). Self-reported diagnosis of heart disease: results from the SHIELD study. International Journal of Clinical Practice. 63(5). 726–734. 1 indexed citations

15.

Grandy, Susan, et al.. (2008). Quality of life and depression of people living with type 2 diabetes mellitus and those at low and high risk for type 2 diabetes: findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD). International Journal of Clinical Practice. 62(4). 562–568. 78 indexed citations

16.

Lewis, Sandra J., et al.. (2008). Self-reported prevalence and awareness of metabolic syndrome: findings from SHIELD. International Journal of Clinical Practice. 62(8). 1168–1176. 33 indexed citations

17.

Fox, Kathleen M., et al.. (2008). Out-of-pocket expenses and healthcare resource utilization among individuals with or at risk of diabetes mellitus. Current Medical Research and Opinion. 24(12). 3323–3329. 16 indexed citations

18.

Bays, Harold, Nathaniel G. Clark, James R. Gavin, et al.. (2007). Prevalence of self-reported diagnosis of diabetes mellitus and associated risk factors in a national survey in the US population: SHIELD (Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes). BMC Public Health. 7(1). 277–277. 66 indexed citations

19.

Bays, Harold, et al.. (2007). The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys. International Journal of Clinical Practice. 61(5). 737–747. 389 indexed citations

20.

Neutel, Joel M., David H.G. Smith, Diana J. Wallin, et al.. (1994). A Comparison of Intravenous Nicardipine and Sodium Nitroprusside in the Immediate Treatment of Severe Hypertension. American Journal of Hypertension. 7(7_Pt_1). 623–628. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact